ExpreS2ion Biotech Holding AB (FRA:5JD0) Marketable Securities : €0.00 Mil (As of Dec. 2024)

View and export this data going back to 2020. Start your Free Trial

What is ExpreS2ion Biotech Holding AB Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. ExpreS2ion Biotech Holding AB's Marketable Securities for the quarter that ended in Dec. 2024 was €0.00 Mil.

ExpreS2ion Biotech Holding AB Marketable Securities Historical Data

The historical data trend for ExpreS2ion Biotech Holding AB's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ExpreS2ion Biotech Holding AB Marketable Securities Chart

ExpreS2ion Biotech Holding AB Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Marketable Securities

Get a 7-Day Free Trial

9.91

ExpreS2ion Biotech Holding AB Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Marketable Securities	Get a 7-Day Free Trial															-	-	-	-	-

ExpreS2ion Biotech Holding AB Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

ExpreS2ion Biotech Holding AB (FRA:5JD0) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

ExpreS2ion Biotech Holding AB Marketable Securities Related Terms

Thank you for viewing the detailed overview of ExpreS2ion Biotech Holding AB's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.

ExpreS2ion Biotech Holding AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ExpreS2ion Biotech Holding AB (FRA:5JD0) » Definitions » Marketable Securities

Comparable Companies

Traded in Other Exchanges

EXPRS2:Sweden

Address

c/o Mindpark, Ronnowsgatan 8c, Helsingborg, SWE, S-252 25

Website

https://www.expres2ionbio.com

ExpreS2ion Biotech Holding AB has developed a technology platform, ExpreS2, for fast and efficient non-clinical development and production of complex proteins for new vaccines and diagnostics. ExpreS2 is regulatorily validated for clinical supply. The platform includes functionally modified glycosylation variants for enhanced immunogenicity and pharmacokinetics. The company has produced more than 500 proteins and virus-like particles (VLPs) in collaboration with research institutions and companies.

ExpreS2ion Biotech Holding AB Headlines

No Headlines